Cai‐Guo Yu

445 total citations
30 papers, 311 citations indexed

About

Cai‐Guo Yu is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Cai‐Guo Yu has authored 30 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Cai‐Guo Yu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Heavy Metal Exposure and Toxicity (6 papers) and Lipid metabolism and disorders (5 papers). Cai‐Guo Yu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Heavy Metal Exposure and Toxicity (6 papers) and Lipid metabolism and disorders (5 papers). Cai‐Guo Yu collaborates with scholars based in China, Belgium and Netherlands. Cai‐Guo Yu's co-authors include Yingmei Feng, Jan A. Staessen, Lutgarde Thijs, Xuhong Wang, Longyan Yang, Dong Zhao, Dong Zhao, Zhen‐Yu Zhang, Fang‐Fei Wei and Ning Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Cai‐Guo Yu

29 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cai‐Guo Yu China 11 101 83 70 51 41 30 311
Honglin Hu China 11 86 0.9× 34 0.4× 48 0.7× 29 0.6× 30 0.7× 28 310
Maximiliano Martín Argentina 8 96 1.0× 47 0.6× 41 0.6× 87 1.7× 29 0.7× 28 358
Remzi Abalı Türkiye 14 72 0.7× 77 0.9× 81 1.2× 35 0.7× 15 0.4× 40 532
Merve Ergin Türkiye 13 42 0.4× 42 0.5× 71 1.0× 47 0.9× 8 0.2× 40 457
Kalle Sipilä Finland 11 57 0.6× 165 2.0× 30 0.4× 29 0.6× 13 0.3× 28 375
Huilei Zhao China 9 143 1.4× 157 1.9× 38 0.5× 46 0.9× 15 0.4× 16 342
Kohei Uriu Japan 12 52 0.5× 48 0.6× 52 0.7× 23 0.5× 89 2.2× 33 393
Yanjiao Wang China 11 36 0.4× 37 0.4× 92 1.3× 54 1.1× 39 1.0× 29 361

Countries citing papers authored by Cai‐Guo Yu

Since Specialization
Citations

This map shows the geographic impact of Cai‐Guo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cai‐Guo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cai‐Guo Yu more than expected).

Fields of papers citing papers by Cai‐Guo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cai‐Guo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cai‐Guo Yu. The network helps show where Cai‐Guo Yu may publish in the future.

Co-authorship network of co-authors of Cai‐Guo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Cai‐Guo Yu. A scholar is included among the top collaborators of Cai‐Guo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cai‐Guo Yu. Cai‐Guo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lu, Jing Ke, Qianqian Zhao, et al.. (2025). Association between metabolic visceral fat score and left ventricular hypertrophy in individuals with type 2 diabetes. Diabetology & Metabolic Syndrome. 17(1). 81–81.
2.
Li, Kun, Cai‐Guo Yu, Ruili Yin, et al.. (2024). Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients. Journal of Diabetes Investigation. 15(12). 1763–1772. 1 indexed citations
3.
Yu, Cai‐Guo, et al.. (2024). Primary aldosteronism with postoperative elevation of aldosterone treated effectively by finerenone: A case report. Journal of Clinical Hypertension. 26(9). 1116–1120. 2 indexed citations
4.
Yu, Cai‐Guo, et al.. (2022). The Association Between Fecal Short-Chain Fatty Acids, Gut Microbiota, and Visceral Fat in Monozygotic Twin Pairs. SHILAP Revista de lepidopterología. 15 indexed citations
5.
Yu, Yu‐Ling, Lutgarde Thijs, Dongmei Wei, et al.. (2022). Two-Year Responses of Renal Function to First Occupational Lead Exposure. Kidney International Reports. 7(6). 1198–1209. 7 indexed citations
6.
Yu, Yu‐Ling, Lutgarde Thijs, Cai‐Guo Yu, et al.. (2021). Two-Year Responses of Heart Rate and Heart Rate Variability to First Occupational Lead Exposure. Hypertension. 77(5). 1775–1786. 6 indexed citations
7.
Yu, Ke, Cai‐Guo Yu, Xiaobo Wang, et al.. (2021). Metabolites of gut microbiome are associated with glucose metabolism in non-diabetic obese adults: a Chinese monozygotic twin study. Diabetology & Metabolic Syndrome. 13(1). 106–106. 3 indexed citations
8.
Yu, Yu‐Ling, Lutgarde Thijs, Nelly D. Saenen, et al.. (2020). Two-year neurocognitive responses to first occupational lead exposure. Scandinavian Journal of Work Environment & Health. 47(3). 233–243. 5 indexed citations
9.
Yu, Cai‐Guo, Wen‐Yi Yang, Nelly D. Saenen, et al.. (2019). Neurocognitive function in relation to blood lead among young men prior to chronic occupational exposure. Scandinavian Journal of Work Environment & Health. 45(3). 298–307. 7 indexed citations
10.
Yu, Cai‐Guo, Fang‐Fei Wei, Wen‐Yi Yang, et al.. (2019). Heart rate variability and peripheral nerve conduction velocity in relation to blood lead in newly hired lead workers. Occupational and Environmental Medicine. 76(6). 382–388. 5 indexed citations
11.
Wei, Fang‐Fei, Lutgarde Thijs, Nicholas Cauwenberghs, et al.. (2019). Central Hemodynamics in Relation to Circulating Desphospho‐Uncarboxylated Matrix Gla Protein: A Population Study. Journal of the American Heart Association. 8(7). e011960–e011960. 12 indexed citations
12.
Wei, Fang‐Fei, Lutgarde Thijs, Cai‐Guo Yu, et al.. (2019). Retinal Microvasculature in Relation to Central Hemodynamics in a Flemish Population. Hypertension. 74(3). 606–613. 8 indexed citations
13.
Yu, Cai‐Guo, Fang‐Fei Wei, Zhen‐Yu Zhang, et al.. (2019). Central hemodynamics in relation to low-level environmental lead exposure. Blood Pressure. 29(3). 157–167. 5 indexed citations
14.
Yu, Cai‐Guo, Longyan Yang, Jing Ke, et al.. (2018). Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients. American Journal of Ophthalmology. 191. 34–41. 17 indexed citations
15.
Zhang, Yuanyuan, Rongxin Sun, Lijie Zhang, et al.. (2018). Adverse Impact of Hashimoto's Thyroiditis on Pancreatic Beta-Cell Function in Type 2 Diabetic Patients. Diabetes. 67(Supplement_1). 2 indexed citations
16.
Yu, Cai‐Guo, Ying Fu, Ning Zhang, et al.. (2017). Fighting Type-2 Diabetes: Present and Future Perspectives. Current Medicinal Chemistry. 26(10). 1891–1907. 14 indexed citations
17.
Yu, Cai‐Guo, Ning Zhang, Yan Ma, et al.. (2016). Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?. Stem Cells International. 2016(1). 1803989–1803989. 27 indexed citations
18.
Feng, Yingmei, Dong Zhao, Ning Zhang, et al.. (2016). Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People. PLoS ONE. 11(4). e0153171–e0153171. 31 indexed citations
19.
Zhao, Dong, et al.. (2016). Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients. Cardiovascular Diabetology. 15(1). 132–132. 22 indexed citations
20.
Chen, Yi-Wen, Dong Zhao, Cai‐Guo Yu, et al.. (2015). High Prevalence of Lower Extremity Peripheral Artery Disease in Type 2 Diabetes Patients with Proliferative Diabetic Retinopathy. PLoS ONE. 10(3). e0122022–e0122022. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Honglin Hu Breakdown of academic impact, for papers by Maximiliano Martín Breakdown of academic impact, for papers by Remzi Abalı Breakdown of academic impact, for papers by Merve Ergin Breakdown of academic impact, for papers by Kalle Sipilä Breakdown of academic impact, for papers by Huilei Zhao Breakdown of academic impact, for papers by Kohei Uriu Breakdown of academic impact, for papers by Yanjiao Wang
Rankless by CCL
2026